[
  {
    "ts": null,
    "headline": "Pfizer : Provides Update on U.S. Regulatory Review of TALZENNA in Combination with XTANDI for Broader Use in Metastatic Castration-Resistant Prostate Cancer",
    "summary": "Friday, June 13, 2025 - 04:23pm Share New York, June 13, 2025 - Pfizer Inc. today announced the U.S. Food and Drug Administration's decision on the supplemental New Drug Application for TALZENNA® ...",
    "url": "https://finnhub.io/api/news?id=f960d1de4e53798bf3f0bb92caaf919bb2719efe564a99da4d421a9eff67282c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749834424,
      "headline": "Pfizer : Provides Update on U.S. Regulatory Review of TALZENNA in Combination with XTANDI for Broader Use in Metastatic Castration-Resistant Prostate Cancer",
      "id": 135256901,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Friday, June 13, 2025 - 04:23pm Share New York, June 13, 2025 - Pfizer Inc. today announced the U.S. Food and Drug Administration's decision on the supplemental New Drug Application for TALZENNA® ...",
      "url": "https://finnhub.io/api/news?id=f960d1de4e53798bf3f0bb92caaf919bb2719efe564a99da4d421a9eff67282c"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. stock underperforms Friday when compared to competitors",
    "summary": "Pfizer Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=e1c04cba1b5a3e4802a6a42c238862a4c83ff78154ac7e1fd4d4bebe8778968c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749832560,
      "headline": "Pfizer Inc. stock underperforms Friday when compared to competitors",
      "id": 135305079,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=e1c04cba1b5a3e4802a6a42c238862a4c83ff78154ac7e1fd4d4bebe8778968c"
    }
  },
  {
    "ts": null,
    "headline": "JPMorgan biotech/pharma analysts hold analyst/industry conference call",
    "summary": "US SMid Biotech Analyst Rama and US Major & Specialty Pharmaceuticals Analyst Schott, along with Dr. Charles Ryan, Genitourinary Medical Oncologist at Memorial Sloan Kettering Cancer Center discuss the evolving treatment landscape in prostate cancer (relevant companies PFE ORIC JNJ) on an Analyst/Industry conference call to be held on June 12 at 2 pm. Webcast Link Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Sto",
    "url": "https://finnhub.io/api/news?id=123b38920801599ad83f4172beb0578ba7dbc2df2d6aa746ffce0e30b7221158",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749828608,
      "headline": "JPMorgan biotech/pharma analysts hold analyst/industry conference call",
      "id": 135251052,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "US SMid Biotech Analyst Rama and US Major & Specialty Pharmaceuticals Analyst Schott, along with Dr. Charles Ryan, Genitourinary Medical Oncologist at Memorial Sloan Kettering Cancer Center discuss the evolving treatment landscape in prostate cancer (relevant companies PFE ORIC JNJ) on an Analyst/Industry conference call to be held on June 12 at 2 pm. Webcast Link Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Sto",
      "url": "https://finnhub.io/api/news?id=123b38920801599ad83f4172beb0578ba7dbc2df2d6aa746ffce0e30b7221158"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Pflash: A Spotlight on Pfizer's Breast Cancer Portfolio Transcript",
    "summary": "REFINITIV STREETEVENTS EDITED TRANSCRIPT PFE.N - Pfizer Pflash: A Spotlight on Pfizer Breast Cancer Portfolio EVENT DATE/TIME: JUNE 12, 2025 /...",
    "url": "https://finnhub.io/api/news?id=af33f1212f8bd61f9edfd9228eac50a432826448e9b2e6f2175818e06c35e59e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749824646,
      "headline": "Pfizer Pflash: A Spotlight on Pfizer's Breast Cancer Portfolio Transcript",
      "id": 135255811,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "REFINITIV STREETEVENTS EDITED TRANSCRIPT PFE.N - Pfizer Pflash: A Spotlight on Pfizer Breast Cancer Portfolio EVENT DATE/TIME: JUNE 12, 2025 /...",
      "url": "https://finnhub.io/api/news?id=af33f1212f8bd61f9edfd9228eac50a432826448e9b2e6f2175818e06c35e59e"
    }
  },
  {
    "ts": null,
    "headline": "Novartis AG (NVS) Hit a 52 Week High, Can the Run Continue?",
    "summary": "Novartis (NVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
    "url": "https://finnhub.io/api/news?id=a2a7dff2767e9d69d54754f2bcf19ec04b193b101141dfa5ed5e0df95b6a5820",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749820505,
      "headline": "Novartis AG (NVS) Hit a 52 Week High, Can the Run Continue?",
      "id": 135248082,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Novartis (NVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
      "url": "https://finnhub.io/api/news?id=a2a7dff2767e9d69d54754f2bcf19ec04b193b101141dfa5ed5e0df95b6a5820"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer : 2024 Impact Report Highlights Accomplishments in Sustainability, Responsibility",
    "summary": "When Pfizer talks about making breakthroughs that change patients' - and people's - lives, we aren't simply referring to scientific discovery and game-changing medicines. We're talking about the...",
    "url": "https://finnhub.io/api/news?id=68086b2a26de5b2d619503ee6e19cd3621d7fbbbdab7b0778f1d2e2141ece4b7",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749814926,
      "headline": "Pfizer : 2024 Impact Report Highlights Accomplishments in Sustainability, Responsibility",
      "id": 135251985,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "When Pfizer talks about making breakthroughs that change patients' - and people's - lives, we aren't simply referring to scientific discovery and game-changing medicines. We're talking about the...",
      "url": "https://finnhub.io/api/news?id=68086b2a26de5b2d619503ee6e19cd3621d7fbbbdab7b0778f1d2e2141ece4b7"
    }
  }
]